List of Tables
Table 1. Global Oral TYK2 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral TYK2 Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Oral TYK2 Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral TYK2 Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral TYK2 Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral TYK2 Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral TYK2 Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral TYK2 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral TYK2 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral TYK2 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral TYK2 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Oral TYK2 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral TYK2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral TYK2 Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral TYK2 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral TYK2 Inhibitors Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral TYK2 Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global Oral TYK2 Inhibitors Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral TYK2 Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global Oral TYK2 Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global Oral TYK2 Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America Oral TYK2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral TYK2 Inhibitors Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral TYK2 Inhibitors Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral TYK2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral TYK2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral TYK2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral TYK2 Inhibitors Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral TYK2 Inhibitors Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral TYK2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral TYK2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral TYK2 Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral TYK2 Inhibitors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral TYK2 Inhibitors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral TYK2 Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral TYK2 Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral TYK2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral TYK2 Inhibitors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral TYK2 Inhibitors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral TYK2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral TYK2 Inhibitors Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral TYK2 Inhibitors Sales (K Units) by Type (2019-2024)
Table 51. Global Oral TYK2 Inhibitors Sales (K Units) by Type (2025-2030)
Table 52. Global Oral TYK2 Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global Oral TYK2 Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global Oral TYK2 Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral TYK2 Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global Oral TYK2 Inhibitors Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral TYK2 Inhibitors Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral TYK2 Inhibitors Sales (K Units) by Application (2019-2024)
Table 61. Global Oral TYK2 Inhibitors Sales (K Units) by Application (2025-2030)
Table 62. Global Oral TYK2 Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global Oral TYK2 Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global Oral TYK2 Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral TYK2 Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global Oral TYK2 Inhibitors Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral TYK2 Inhibitors Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb Oral TYK2 Inhibitors Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. InnoCare Company Information
Table 76. InnoCare Description and Business Overview
Table 77. InnoCare Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. InnoCare Oral TYK2 Inhibitors Product
Table 79. InnoCare Recent Developments/Updates
Table 80. Takeda (Nimbus Therapeutics) Company Information
Table 81. Takeda (Nimbus Therapeutics) Description and Business Overview
Table 82. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product
Table 84. Takeda (Nimbus Therapeutics) Recent Developments/Updates
Table 85. Inventisbio Company Information
Table 86. Inventisbio Description and Business Overview
Table 87. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Inventisbio Oral TYK2 Inhibitors Product
Table 89. Inventisbio Recent Developments/Updates
Table 90. Changzhou Hengbang Pharmaceutical Company Information
Table 91. Changzhou Hengbang Pharmaceutical Description and Business Overview
Table 92. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product
Table 94. Changzhou Hengbang Pharmaceutical Recent Developments/Updates
Table 95. Ventyx Biosciences Company Information
Table 96. Ventyx Biosciences Description and Business Overview
Table 97. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ventyx Biosciences Oral TYK2 Inhibitors Product
Table 99. Ventyx Biosciences Recent Developments/Updates
Table 100. Galapagos NV Company Information
Table 101. Galapagos NV Description and Business Overview
Table 102. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Galapagos NV Oral TYK2 Inhibitors Product
Table 104. Galapagos NV Recent Developments/Updates
Table 105. Highlightll Pharma Company Information
Table 106. Highlightll Pharma Description and Business Overview
Table 107. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Highlightll Pharma Oral TYK2 Inhibitors Product
Table 109. Highlightll Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Oral TYK2 Inhibitors Distributors List
Table 113. Oral TYK2 Inhibitors Customers List
Table 114. Oral TYK2 Inhibitors Market Trends
Table 115. Oral TYK2 Inhibitors Market Drivers
Table 116. Oral TYK2 Inhibitors Market Challenges
Table 117. Oral TYK2 Inhibitors Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral TYK2 Inhibitors
Figure 2. Global Oral TYK2 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral TYK2 Inhibitors Market Share by Type: 2023 & 2030
Figure 4. Single-target Inhibitors Product Picture
Figure 5. Dual-target Inhibitors Product Picture
Figure 6. Global Oral TYK2 Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral TYK2 Inhibitors Market Share by Application: 2023 & 2030
Figure 8. Psoriasis
Figure 9. Systemic Lupus Erythematosus
Figure 10. Dermatitis
Figure 11. Arthritis
Figure 12. Others
Figure 13. Global Oral TYK2 Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Oral TYK2 Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 15. Global Oral TYK2 Inhibitors Sales (2019-2030) & (K Units)
Figure 16. Global Oral TYK2 Inhibitors Average Price (US$/Unit) & (2019-2030)
Figure 17. Oral TYK2 Inhibitors Report Years Considered
Figure 18. Oral TYK2 Inhibitors Sales Share by Manufacturers in 2023
Figure 19. Global Oral TYK2 Inhibitors Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Oral TYK2 Inhibitors Players: Market Share by Revenue in Oral TYK2 Inhibitors in 2023
Figure 21. Oral TYK2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Oral TYK2 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Oral TYK2 Inhibitors Sales Market Share by Country (2019-2030)
Figure 24. North America Oral TYK2 Inhibitors Revenue Market Share by Country (2019-2030)
Figure 25. United States Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Oral TYK2 Inhibitors Sales Market Share by Country (2019-2030)
Figure 28. Europe Oral TYK2 Inhibitors Revenue Market Share by Country (2019-2030)
Figure 29. Germany Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Oral TYK2 Inhibitors Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Oral TYK2 Inhibitors Revenue Market Share by Region (2019-2030)
Figure 36. China Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oral TYK2 Inhibitors Sales Market Share by Country (2019-2030)
Figure 44. Mexico Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Oral TYK2 Inhibitors Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Oral TYK2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oral TYK2 Inhibitors by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oral TYK2 Inhibitors by Type (2019-2030)
Figure 55. Global Oral TYK2 Inhibitors Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oral TYK2 Inhibitors by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oral TYK2 Inhibitors by Application (2019-2030)
Figure 58. Global Oral TYK2 Inhibitors Price (US$/Unit) by Application (2019-2030)
Figure 59. Oral TYK2 Inhibitors Value Chain
Figure 60. Oral TYK2 Inhibitors Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
